The document summarizes WHO Regional Office for Europe’s programs and actions for public health. It discusses increasing life expectancy in the region from 75 to 82 years on average but notes inequities persist. It also outlines priority areas for action like investing in health promotion, tackling noncommunicable diseases, and strengthening health systems and emergency preparedness. Specific country programs are highlighted in areas like reducing tobacco use, eliminating measles and rubella, and improving migrant health.
This document summarizes the work of the WHO Regional Office for Europe from 2010 to 2014. It outlines the office's strategic priorities, including improving health systems, addressing noncommunicable and communicable diseases, and strengthening emergency preparedness. Key achievements are highlighted, such as increased life expectancy in Europe, declines in premature mortality from noncommunicable diseases, and higher rates of treatment for HIV/AIDS and tuberculosis. Challenges remaining include health inequities and curbing the HIV epidemic. The report emphasizes multisectoral collaboration and a life-course approach to tackle challenges and promote healthier, more equitable and sustainable societies in Europe.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
This presentation is part of the report presented by the WHO Regional Director Zsuzsanna Jakab at the 63rd session of the WHO Regional Committee for Europe in Çeşme Izmir, Turkey, on 16 September 2013.
1) The document outlines the TB and MDR-TB burden in the WHO European Region, with 41% of cases occurring in Europe and 25% in Southeast Asia.
2) It summarizes achievements of the previous TB Action Plan from 2015, including reducing the estimated prevalence of MDR-TB cases and increasing MDR-TB detection and treatment coverage.
3) The new TB Action Plan for 2016-2020 aims to build on these achievements through full scale-up of rapid diagnosis, expanding patient-centered care models, shorter treatment regimens, preventive therapy, and intersectoral approaches to reduce inequities and progress toward a TB-free Europe.
Health 2020 is a new European policy framework for health and well-being adopted by the WHO Regional Committee for Europe in 2012. It aims to significantly improve population health and well-being, reduce health inequities, and ensure sustainable health systems. Health 2020 recognizes that health challenges require involvement across all levels of government and society. It provides an adaptable framework for integrated interventions to address major health issues like noncommunicable and communicable diseases.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 67th session of the WHO Regional Committee for Europe (Budapest, Hungary, 11–14 September 2017)
The document summarizes WHO Regional Office for Europe’s programs and actions for public health. It discusses increasing life expectancy in the region from 75 to 82 years on average but notes inequities persist. It also outlines priority areas for action like investing in health promotion, tackling noncommunicable diseases, and strengthening health systems and emergency preparedness. Specific country programs are highlighted in areas like reducing tobacco use, eliminating measles and rubella, and improving migrant health.
This document summarizes the work of the WHO Regional Office for Europe from 2010 to 2014. It outlines the office's strategic priorities, including improving health systems, addressing noncommunicable and communicable diseases, and strengthening emergency preparedness. Key achievements are highlighted, such as increased life expectancy in Europe, declines in premature mortality from noncommunicable diseases, and higher rates of treatment for HIV/AIDS and tuberculosis. Challenges remaining include health inequities and curbing the HIV epidemic. The report emphasizes multisectoral collaboration and a life-course approach to tackle challenges and promote healthier, more equitable and sustainable societies in Europe.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
This presentation is part of the report presented by the WHO Regional Director Zsuzsanna Jakab at the 63rd session of the WHO Regional Committee for Europe in Çeşme Izmir, Turkey, on 16 September 2013.
1) The document outlines the TB and MDR-TB burden in the WHO European Region, with 41% of cases occurring in Europe and 25% in Southeast Asia.
2) It summarizes achievements of the previous TB Action Plan from 2015, including reducing the estimated prevalence of MDR-TB cases and increasing MDR-TB detection and treatment coverage.
3) The new TB Action Plan for 2016-2020 aims to build on these achievements through full scale-up of rapid diagnosis, expanding patient-centered care models, shorter treatment regimens, preventive therapy, and intersectoral approaches to reduce inequities and progress toward a TB-free Europe.
Health 2020 is a new European policy framework for health and well-being adopted by the WHO Regional Committee for Europe in 2012. It aims to significantly improve population health and well-being, reduce health inequities, and ensure sustainable health systems. Health 2020 recognizes that health challenges require involvement across all levels of government and society. It provides an adaptable framework for integrated interventions to address major health issues like noncommunicable and communicable diseases.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 67th session of the WHO Regional Committee for Europe (Budapest, Hungary, 11–14 September 2017)
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the Advanced Training and Conference on Health Economics (24 June 2015, Budapest, Hungary)
This document discusses emerging infectious diseases and antimicrobial resistance as key issues for health governance in Europe. It provides information on progress made in several areas:
1) Establishing a WHO European action plan to address antimicrobial resistance that has been adopted by all 53 member states.
2) Expanding infectious disease surveillance networks to cover all member states.
3) Collecting region-wide data on antimicrobial use and consumption to support action by countries.
4) Adopting strategies in the European action plan for HIV/AIDS from 2012-2015 to reduce vulnerability and optimize prevention and treatment outcomes.
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
The document outlines an action plan for the health sector response to HIV in Europe with the vision of ending the AIDS epidemic as a public health threat by 2030. It identifies five strategic directions: (1) using data to guide focused services, (2) prioritizing prevention and treatment interventions, (3) delivering equitable services based on human rights, (4) financing a sustainable response, and (5) stimulating innovation. Fast-track actions are outlined under each strategic direction to strengthen coordination, expand testing and treatment, eliminate transmission, and transition to domestic financing. The draft resolution calls on countries to review strategies, strengthen prevention, ensure commitment and financing, and monitor implementation of the plan.
The document summarizes key points from a speech given by the WHO Regional Director for Europe on health challenges in the European region and strategies to address them. The main points are:
1) There are significant health inequities within and between countries in the European region in terms of life expectancy and healthy life expectancy. Nordic countries have some of the highest rates.
2) Investing in public health, disease prevention, and addressing social determinants of health through intersectoral policies can help reduce inequities and improve population health outcomes.
3) The Health 2020 policy framework and examples from countries like Norway that have strengthened public health infrastructure and implemented intersectoral governance approaches provide guidance for addressing challenges and closing
Presentation by WHO Regional Director for Europe, Ms Zsuzsanna Jakab, to the 62nd session of the WHO Regional Committee for Europe, on 10 September 2012.
Presented at the 66th session of the WHO Regional Committee for Europe by:
Dr Oleg Chestnov, Assistant Director-General, WHO
Dr Jill Farrington, Acting Head, NCD Project Office, Moscow
Dr Gauden Galea, Director, Noncommunicable Diseases and
Promoting Health through the Life-course, WHO/Europe
Strategic directions for the health sector response to viral hepatitis include:
1) Improving surveillance and estimates of disease burden to focus action.
2) Defining essential intervention packages and setting national targets for coverage.
3) Addressing barriers like stigma to make hepatitis services accessible for all populations.
4) Building political commitment and innovative funding approaches for sustainable financing.
5) Prioritizing hepatitis research and rapidly translating findings into practice.
The action plan aims to halt transmission of hepatitis and ensure treatment access for all by 2030.
COPD is a serious lung disease affecting 4-10% of European adults that is often preventable through reducing risk factors like smoking and air pollution. It places a high economic burden on healthcare systems and is expected to become the third leading cause of death worldwide by 2030. The document calls for 22 concrete actions the EU can take to improve COPD prevention, care, research, education and patient empowerment. These include increasing public awareness campaigns, strengthening tobacco control policies, improving screening and diagnosis, developing rehabilitation programs, increasing dedicated research funding, and supporting patient education initiatives.
Dr Zsuzsanna Jakab, WHO Regional Director for Europe,Policy Dialogue on Health System and Public Health Reform in Cyprus: Health in the 21st Century, 26–27 September 2017, Nicosia, Cyprus
This document summarizes a presentation on health in Europe and priorities for the future. It discusses increasing life expectancy and healthy life years across the region. However, there remain discrepancies between countries. Priorities include achieving universal health coverage, tackling non-communicable and communicable diseases, strengthening health systems, addressing social and environmental determinants of health, and improving emergency preparedness. Investing in public health through policies like tobacco control provides high economic returns. Accelerating progress on disease prevention, immunization, viral hepatitis and antimicrobial resistance is needed.
The WHO Health Emergencies Programme in the European Region focuses on several priority areas:
1) Country health emergency preparedness and International Health Regulations core capacity building.
2) Health emergency information and risk assessment through 24/7 monitoring and early detection of public health events.
3) Emergency operations management for graded health emergencies and coordination of partner responses.
4) Infectious hazard management including prevention and control strategies for high-threat pathogens.
The Programme operates through core services and is working to ensure countries have the capacities for all-hazards health emergency risk management.
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
Presented by Piroska Östlin, Director and Åsa Nihlén, Technical Officer, Division of Policy and Governance for Health and Well-being, WHO/Europe, at the 66th session of the WHO Regional Committee for Europe.
This document proposes ways for the EU to strengthen its role in global health. It recommends that the EU:
1) Seek stronger leadership and coordination of global health actors like the WHO to improve governance.
2) Increase support to help all countries achieve universal healthcare coverage and make faster progress on health-related UN Millennium Development Goals.
3) Promote policy coherence across EU policies affecting health like trade, development aid, migration, and climate change.
Romania’s current tuberculosis (TB) problems illustrate the consequence of what happens when the challenges of such a disease are, for many years, met with lethargy rather than action. The country currently has about 1/4 of all TB cases in the EU and European Economic Area, even though it has just under 4% of the area’s total population. What are the main barriers to addressing TB in Romania? To what extent are there opportunities for change?
WHO Regional Office for Europe's programmes and actions in Tajikistan.
1) The WHO is working with countries in the European Region, including Tajikistan, to implement their Health 2020 strategy to improve health, reduce inequities, and move towards more sustainable health systems.
2) Key priority areas for Tajikistan include improving child and adolescent health, transforming maternal health, tackling noncommunicable diseases, and combating communicable diseases like tuberculosis and HIV/AIDS.
3) The WHO is providing support to Tajikistan in developing policies and strengthening their health systems to address their major health challenges through a life course approach.
The document provides a summary of the work of the WHO Regional Office for Europe over the past year. It discusses progress made in implementing the UN's 2030 Agenda for Sustainable Development and the Health 2020 strategy. It highlights achievements in reducing premature mortality and increasing life expectancy. It also outlines ongoing challenges in ensuring health equity and implementing intersectoral collaboration to address social determinants of health.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the Advanced Training and Conference on Health Economics (24 June 2015, Budapest, Hungary)
This document discusses emerging infectious diseases and antimicrobial resistance as key issues for health governance in Europe. It provides information on progress made in several areas:
1) Establishing a WHO European action plan to address antimicrobial resistance that has been adopted by all 53 member states.
2) Expanding infectious disease surveillance networks to cover all member states.
3) Collecting region-wide data on antimicrobial use and consumption to support action by countries.
4) Adopting strategies in the European action plan for HIV/AIDS from 2012-2015 to reduce vulnerability and optimize prevention and treatment outcomes.
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
The document outlines an action plan for the health sector response to HIV in Europe with the vision of ending the AIDS epidemic as a public health threat by 2030. It identifies five strategic directions: (1) using data to guide focused services, (2) prioritizing prevention and treatment interventions, (3) delivering equitable services based on human rights, (4) financing a sustainable response, and (5) stimulating innovation. Fast-track actions are outlined under each strategic direction to strengthen coordination, expand testing and treatment, eliminate transmission, and transition to domestic financing. The draft resolution calls on countries to review strategies, strengthen prevention, ensure commitment and financing, and monitor implementation of the plan.
The document summarizes key points from a speech given by the WHO Regional Director for Europe on health challenges in the European region and strategies to address them. The main points are:
1) There are significant health inequities within and between countries in the European region in terms of life expectancy and healthy life expectancy. Nordic countries have some of the highest rates.
2) Investing in public health, disease prevention, and addressing social determinants of health through intersectoral policies can help reduce inequities and improve population health outcomes.
3) The Health 2020 policy framework and examples from countries like Norway that have strengthened public health infrastructure and implemented intersectoral governance approaches provide guidance for addressing challenges and closing
Presentation by WHO Regional Director for Europe, Ms Zsuzsanna Jakab, to the 62nd session of the WHO Regional Committee for Europe, on 10 September 2012.
Presented at the 66th session of the WHO Regional Committee for Europe by:
Dr Oleg Chestnov, Assistant Director-General, WHO
Dr Jill Farrington, Acting Head, NCD Project Office, Moscow
Dr Gauden Galea, Director, Noncommunicable Diseases and
Promoting Health through the Life-course, WHO/Europe
Strategic directions for the health sector response to viral hepatitis include:
1) Improving surveillance and estimates of disease burden to focus action.
2) Defining essential intervention packages and setting national targets for coverage.
3) Addressing barriers like stigma to make hepatitis services accessible for all populations.
4) Building political commitment and innovative funding approaches for sustainable financing.
5) Prioritizing hepatitis research and rapidly translating findings into practice.
The action plan aims to halt transmission of hepatitis and ensure treatment access for all by 2030.
COPD is a serious lung disease affecting 4-10% of European adults that is often preventable through reducing risk factors like smoking and air pollution. It places a high economic burden on healthcare systems and is expected to become the third leading cause of death worldwide by 2030. The document calls for 22 concrete actions the EU can take to improve COPD prevention, care, research, education and patient empowerment. These include increasing public awareness campaigns, strengthening tobacco control policies, improving screening and diagnosis, developing rehabilitation programs, increasing dedicated research funding, and supporting patient education initiatives.
Dr Zsuzsanna Jakab, WHO Regional Director for Europe,Policy Dialogue on Health System and Public Health Reform in Cyprus: Health in the 21st Century, 26–27 September 2017, Nicosia, Cyprus
This document summarizes a presentation on health in Europe and priorities for the future. It discusses increasing life expectancy and healthy life years across the region. However, there remain discrepancies between countries. Priorities include achieving universal health coverage, tackling non-communicable and communicable diseases, strengthening health systems, addressing social and environmental determinants of health, and improving emergency preparedness. Investing in public health through policies like tobacco control provides high economic returns. Accelerating progress on disease prevention, immunization, viral hepatitis and antimicrobial resistance is needed.
The WHO Health Emergencies Programme in the European Region focuses on several priority areas:
1) Country health emergency preparedness and International Health Regulations core capacity building.
2) Health emergency information and risk assessment through 24/7 monitoring and early detection of public health events.
3) Emergency operations management for graded health emergencies and coordination of partner responses.
4) Infectious hazard management including prevention and control strategies for high-threat pathogens.
The Programme operates through core services and is working to ensure countries have the capacities for all-hazards health emergency risk management.
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
Presented by Piroska Östlin, Director and Åsa Nihlén, Technical Officer, Division of Policy and Governance for Health and Well-being, WHO/Europe, at the 66th session of the WHO Regional Committee for Europe.
This document proposes ways for the EU to strengthen its role in global health. It recommends that the EU:
1) Seek stronger leadership and coordination of global health actors like the WHO to improve governance.
2) Increase support to help all countries achieve universal healthcare coverage and make faster progress on health-related UN Millennium Development Goals.
3) Promote policy coherence across EU policies affecting health like trade, development aid, migration, and climate change.
Romania’s current tuberculosis (TB) problems illustrate the consequence of what happens when the challenges of such a disease are, for many years, met with lethargy rather than action. The country currently has about 1/4 of all TB cases in the EU and European Economic Area, even though it has just under 4% of the area’s total population. What are the main barriers to addressing TB in Romania? To what extent are there opportunities for change?
WHO Regional Office for Europe's programmes and actions in Tajikistan.
1) The WHO is working with countries in the European Region, including Tajikistan, to implement their Health 2020 strategy to improve health, reduce inequities, and move towards more sustainable health systems.
2) Key priority areas for Tajikistan include improving child and adolescent health, transforming maternal health, tackling noncommunicable diseases, and combating communicable diseases like tuberculosis and HIV/AIDS.
3) The WHO is providing support to Tajikistan in developing policies and strengthening their health systems to address their major health challenges through a life course approach.
The document provides a summary of the work of the WHO Regional Office for Europe over the past year. It discusses progress made in implementing the UN's 2030 Agenda for Sustainable Development and the Health 2020 strategy. It highlights achievements in reducing premature mortality and increasing life expectancy. It also outlines ongoing challenges in ensuring health equity and implementing intersectoral collaboration to address social determinants of health.
This document summarizes Dr. Ignac Semmelweis's impact on global health priorities. It discusses how Semmelweis, in the 1800s, discovered that handwashing with chlorine reduced childbed fever and maternal mortality rates. Despite facing criticism, his findings helped establish germ theory and antiseptic practices. Today, hand hygiene and infection prevention remain global priorities to reduce healthcare-associated infections, antimicrobial resistance, and improve maternal and child health outcomes. Semmelweis's legacy demonstrates how simple practices can have enormous impacts on public health.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 7th Meeting of the European Advisory Committee on Health Research (Copenhagen, Denmark, 6 April 2016)
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
presented by Zsuzsanna Jakab, WHO Regional Director for Europe on 18 November 2014 at Ministerial Meeting in Skopje, The former Yugoslav Republic of Macedonia
This document discusses advancing health literacy and social mobilization to achieve the United Nations 2030 Sustainable Development Goals. It outlines the 17 Sustainable Development Goals, including Goal 3 which aims to ensure healthy lives and promote well-being for all at all ages. It notes that improving health literacy levels is crucial for attaining the social, economic, and environmental ambitions of the 2030 Agenda. Broadening and strengthening social mobilization through open dialogue, civil society engagement, and effective partnerships is key to securing health, dignity, and equality for all. Mobilizing communities for health promotion links to achieving multiple Sustainable Development Goals.
The document summarizes a WHO policy framework called Health 2020 that aims to significantly improve population health and well-being in Europe and reduce health inequities. It discusses challenges like uneven health improvements between countries and rising noncommunicable diseases. Health 2020 was developed based on extensive evidence and stakeholder input to promote integrated, upstream approaches addressing social determinants of health through multisectoral collaboration.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: ECDC's HIV expert Anastasia Pharris
a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
This document discusses strengthening health emergency preparedness and response capacities in the Republic of Moldova. It notes that the European Region faces health threats from infectious diseases, natural disasters, and other emergencies. A Joint External Evaluation found that Moldova has some strengths in public health legislation but needs to strengthen specific capacities like surveillance systems, multisectoral coordination, and long-term preparedness planning. The WHO supports Moldova's response to health emergencies and recommends developing a national action plan to build sustainable emergency capacities as part of achieving universal health coverage.
1. The WHO Regional Director for Europe launched the Knowledge Hub on Health and Migration, a multi-stakeholder platform for sharing knowledge and improving public policies around health needs of migrants.
2. An analysis of health indicators in Sicily found higher infant mortality, lower life expectancy, and social inequalities compared to other EU regions in Italy.
3. Reducing health inequities will require action on social, economic, and environmental determinants of health across the life course from early childhood through working years.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Masoud Dara, WHO Regional Office for Europe
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe at the Meeting of the ministers of health of the SEEHN Member States (22 June 2015, Belgrade, Serbia)
This document discusses priority actions for prevention of major non-communicable diseases in the WHO European Region. It highlights smoking, alcohol, overweight and obesity as key risk factors. It provides data on mortality from smoking, smoking prevalence trends, and alcohol consumption in the region. The document calls for greater implementation of WHO FCTC on tobacco control, development of policy toolkits on tobacco and alcohol for member states, and coordination of national and regional action on salt reduction, physical activity promotion, and obesity prevention. The overall goal is to support member states in improving nutrition, physical activity, and reducing health inequalities in the region.
The document discusses Europe's Health 2020 policy and its goals of emphasizing health, well-being, and universal access to care. It outlines the policy's overarching goals of reducing premature mortality and increasing life expectancy in Europe by 2020. It also discusses establishing a single integrated health information system for the 53 European member states to help monitor progress on key indicators and reduce reporting burdens, though acknowledges challenges in achieving this given limitations in health data availability across the region.
This document summarizes measles and rubella surveillance data from the WHO European Region from March 2021 to February 2022. It finds that 22 countries reported 222 measles cases, with the majority (87%) occurring in 10 countries including Tajikistan, Turkey, Belgium, and Poland. 107 rubella cases were reported by 12 countries, with 96 cases in 5 countries including Poland, Turkey, Ukraine, and Germany. The data also examines case trends over time and genotypes in an effort to monitor elimination goals for these vaccine-preventable diseases.
This document summarizes reported measles cases in the WHO European Region from March 2021 to February 2022. It shows the total number of measles cases and incidence rate per country over this period. The highest numbers of cases were reported in Poland, Germany, Italy, and Ukraine. Overall, there were 222 measles cases reported in March 2021, rising to a peak of 35 cases in October 2021, before declining to 33 cases in February 2022.
The document summarizes measles and rubella surveillance data from the WHO European Region. It provides data on measles and rubella cases, incidence, genotypes, and vaccination coverage from 2021-2022. The top countries for measles and rubella cases in this period are reported, with Turkey, Poland, and Ukraine among those with the highest numbers of measles cases and Poland reporting the most rubella cases.
The document provides an overview of measles and rubella cases and vaccination coverage in the WHO European Region from 2021-2022. It summarizes measles and rubella data for 2021, including the top 10 countries by cases. Turkey had the most measles cases in 2021 while Poland had the most rubella cases. Vaccination coverage for measles-containing vaccines was over 90% from 2010-2021.
The document summarizes measles and rubella surveillance data from the WHO European Region from December 2020 to November 2021. It finds that 148 measles cases were reported in this period, with the majority (89%) occurring in 11 countries including Turkey, France, Poland, and Belgium. 103 rubella cases were reported in the same period, with over 90% concentrated in 5 countries including Italy, Germany, Turkey, and Ukraine. Overall measles and rubella cases have declined in the region since 2018 but surveillance and vaccination efforts need to remain vigilant to prevent further outbreaks.
Reported measles cases for the period November 2020—October 2021 (data as of 02 December 2021).A monthly summary of the epidemiological data on selected vaccine-preventable diseases in the WHO European Region
The document summarizes measles and rubella surveillance data from the WHO European Region from October 2020 to September 2021. It finds that Turkey, Ukraine, and Poland reported the most measles cases, with Turkey reporting 35 cases. It also finds that Azerbaijan, Germany, Turkey, Ukraine, and Poland reported the most rubella cases, with Poland reporting 47 cases. Overall, measles and rubella cases have decreased in the region since 2019, but ongoing vaccination efforts are still needed to eliminate both diseases.
The document provides information on measles and rubella cases in the WHO European Region from September 2020 to August 2021. It summarizes that Turkey, Ukraine, and Poland reported the most measles cases, while Poland, Ukraine, and Turkey reported the most rubella cases. Overall measles and rubella cases have declined compared to previous years but outbreaks still occur periodically in some countries. The document also provides links to additional measles and rubella surveillance resources on the WHO website.
The document provides an overview of measles and rubella cases in the WHO European Region from August 2020 to July 2021. It summarizes measles and rubella data, including the number of reported cases by country, genotype information, and monthly trends over multiple years. Turkey had the highest number of measles cases while Poland had the most rubella cases. Measles cases were highest among unvaccinated children under 5 years old.
The document summarizes measles and rubella surveillance data from the WHO European Region from July 2020 to June 2021. It finds that for measles, Turkey, Ukraine, Belgium, Poland and France reported the most cases, with Turkey reporting 30 cases. For rubella, Italy, Turkey, Germany, Ukraine and Poland reported most of the 80 total cases. The number of measles cases decreased from 2020 to 2021 while the number of rubella cases remained low. Vaccination coverage and outbreaks varied by country.
The document provides measles and rubella surveillance data for the WHO European Region from May 2020 to April 2021. It shows that:
- Kazakhstan reported the highest number of measles cases, while Poland, France, and others also reported cases.
- For rubella, Poland reported the highest number of cases between May 2020 to April 2021, while Italy, Turkey, Germany and Ukraine also reported cases.
- Both measles and rubella cases were highest in 2020 compared to previous years, though rubella cases remained low overall, with 188 cases reported for 2020.
Uzbekistan and Kazakhstan reported the highest numbers of measles cases between April 2020-March 2021, with 446 and 423 cases respectively. Overall, 1,511 measles cases were reported in this period in the WHO European Region, with 96% occurring in the top 10 reporting countries. For rubella, 86 total cases were reported between April 2020-March 2021, with 97% found in the top 5 countries of Italy, Turkey, Germany, Ukraine, and Poland.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
Work of the WHO Regional Office for Europe for public health
1. Work of the
WHO Regional Office
for Europe
for public health
Zsuzsanna Jakab
WHO Regional Director for Europe
17 October 2014
Chisinau, Republic of Moldova
2. Building on the 2010 vision
Life expectancy increased by 5 years but inequities persist
Highest rate in WHO European
Region
Regional average
Lowest rate in Region
Source: European Health for All database (HFA-DB). Copenhagen:
WHO Regional Office for Europe; 2014.
82 years
75 years
68 years
3. Facing the future
Health higher on the
political agenda
Croatia: World Health Day
5. WHO working with Member States
for Health 2020
July 2014: small countries’ meeting in
San Marino for Health 2020
implementation
May 2014: Health 2020 implementation
in the former Yugoslav Republic of
Macedonia
December 2013: meeting on Health
2020 implementation in Turkey
7. Investing in public health interventions
• Clear policy
frameworks and
supportive
strategies
• Strong public health
infrastructure
• Cohesion in health
sector, and better
coordination across
sectors
8. Health 2020: counting on
strong leadership
Montenegro: Zsuzsanna Jakab with
Milo Đukanović, Prime Minister of
Montenegro
San Marino: Zsuzsanna Jakab with
the Captains Regent of San Marino
Kyrgyzstan: Health 2020 launch with
the Prime Minister of Kyrgyzstan and
ministers
12. Child and adolescent health
Estimates of under-5 mortality for
the Caucasus and central Asia
49 per 1000 live births (2005)
36 per 1000 live births (2012)
Republic of Moldova
16 per 1000 live births (2005)
12 per 1000 live births (2012)
13. Action plan on child
maltreatment
Report estimates that in
the Region
• 18 million children have been
sexually abused
• 44 million have been physically
abused
• 55 million have been mentally
abused
14. Transforming maternal
health
Trends in maternal mortality ratio
(estimated deaths per 100 000 live births)
45
40
35
30
25
20
15
10
5
0
1990 1995 2000 2005 2010 2013
WHO
European
Region
-
15. Tackling the Region’s major health
challenges of non-communicable diseases
(NCDs)
Tackling the Region’s major health challenges:
noncommunicable diseases (NCDs)
16. Decreasing premature mortality
from NCDs
250
200
150
100
50
0
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Standardized death rate,
0–64 years, per 100 000 population
Declining premature mortality from circulatory diseases, 2000–2011
European
Region
Eur-A
Eur-B+C
Eur-A: 27 countries
with very low child
and adult mortality
Eur-B: 17 countries
with low child and
adult mortality
Eur-C: 9 countries
with low child but
high adult
mortality
17. Investing in health promotion
and disease prevention
Investments bring returns
in short and medium
terms
Turkey: health promotion event in Ankara with
Dr Mehmet Müezzinoglu, Minister of Health
20. Food and Nutrition Action Plan:
follow-up to Vienna Declaration
Austria: Federal Minister
for Health of Austria and
Zsuzsanna Jakab after
signing the Vienna
Declaration on Nutrition
and Noncommunicable
Diseases in the Context
of Health 2020
21. Reducing tobacco use as a regional priority
28% of all adults in the Region smoke
WHO Director-General Margaret
Chan presents awards to Viktor
Orbán, Prime Minister of Hungary,
and Gurbanguly Berdimuhamedow,
President of Turkmenistan
22. Reducing tobacco use – legal instruments
Hungary: opening of the WHO Framework
Convention on Tobacco Control (WHO FCTC)
meeting in Budapest
23. Reducing tobacco use with the end game in mind
Republic of Moldova: first smoke-free
zones established for children's
playgrounds, 1 June 2014 in Chisinau,
with Deputy Speaker of the Parliament,
deputy minister and WHO staff.
Albania: activities related to an anti-tobacco
campaign
Turkmenistan: Ministerial
Conference on the Prevention and
Control of Noncommunicable
Diseases in the Context of Health
2020, Ashgabat, Turkmenistan
26. Eliminating TB in our lifetime
Denmark: high-level
meeting commemorating
World TB Day 2014, at
which WHO urged
Member States to boost
efforts to eliminate TB by
2050
27. More people receiving HIV/AIDS
treatment
1600000
1400000
1200000
1000000
800000
600000
400000
200000
0
ART eastern Europe ART western and central Europe HIV cases
2009 2010 2011 2012 2013
People diagnosed with HIV and receiving antiretroviral therapy (ART) in Europe, 2009–2013
28. We have not yet managed to curb the
epidemic!
Key populations at higher
risk
• People who inject drugs and
their sexual partners
• Men who have sex with men
• Transgender people
• Sex workers
• Prisoners
• Migrants
29. Scale up evidence-based
interventions
• Deliver high-quality, integrated
services
• Use treatment as a strategic
means, and for prevention
• Implement evidence-based
policies
Russian Federation: Igor Ivanovich Shuvalov, First Deputy
Prime Minister, Russian Federation; Michel Sidibé, Executive
Director of the Joint United Nations Programme on HIV/AIDS
(UNAIDS); and Zsuzsanna Jakab addressing journalists at HIV
conference in Moscow
30. Antimicrobial resistance (AMR):
global health threat
Belarus: staff of WHO, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) and the National Institute for Public Health and the Environment
(RIVM), Netherlands discuss laboratory procedures with hospital laboratory staff as part of a
country assessment on AMR
31. Source: European Centre for Disease Prevention and
Control
Source: WHO Regional Office for Europe
European Antimicrobial
Resistance Surveillance
Network (EARS-Net)
CAESAR (Central Asian and Eastern
European Surveillance of
Antimicrobial Resistance) network
32. European Vaccine Action Plan –
now is the time to act
Her Royal Highness Crown Princess Mary of Denmark,
Patron of the WHO Regional Office for Europe
33. Commitment to eliminating
measles and rubella
35 088 27 132 31 685
9464
29 601 39 367
Measles in 1993: 341 982
cases
Rubella in 2000: 621 039
cases
35. Malaria elimination: within reach
8 884
90 712
32 394
5 074
179 37
100000
90000
80000
70000
60000
50000
40000
30000
20000
10000
0
Cases due to local transmission
Source: WHO centralized information system for infectious diseases (CISID). Copenhagen: WHO Regional Office for Europe; 2014.
40. The Tallinn Charter five years on
Photo: Armo Vask
Estonia: meeting on health systems for health and wealth in the context of Health 2020, October 2013
41. Coordinated, integrated health-service
delivery towards people-centred care
Denmark: memorandum of
understanding between WHO
and the European Forum of
National Nursing and Midwifery
Associations (EFNNMA), signed
by Zsuzsanna Jakab and
Valentina Sarkisova, Chairperson
of the EFNNMA Steering
Committee, in February 2014
42. Universal health coverage:
key strategic focus
Republic of Moldova: National Health Forum, “Towards
universal health coverage through joint efforts of the
government and society”
Tajikistan: flagship course on strengthening health systems
47. Better health for Europe:
equitable and sustainable
• Improve healthy life expectancy, extending the
period of life lived in good health
• Strive for equity in health
• Link health more closely to sustainable
development